Asian press release distribution

Press Releases for Monday, February 1, 2021

KPMG Nominates Virtual Exchange, HKVAX, as 2020 Fintech Leader 22:00 HKT/SGT

嘉利国际设泰国厂房进军汽车市场 20:39 HKT/SGT

嘉利國際設泰國廠房進軍汽車市場 20:37 HKT/SGT

三菱重工業とデンマーク・ヴェスタス社、風力発電設備販売の新会社が営業を開始 17:00 HKT/SGT

Hitachi Launches 'Hitachi Industrial Edge Computer CE series Embedded AI model' 16:22 HKT/SGT

Whiteside Capital Groupが2月にデジタルオークション部門を立ち上げ 16:00 HKT/SGT

Whiteside Capital Groupが2月にデジタルオークション部門を立ち上げ 16:00 HKT/SGT

Asia Pacific Silk Road Investment Company Limited Announces Shareholder Approval for Change of Company Name 15:37 HKT/SGT

문스테이크와 Stake Technologies의 전략적 제휴 체결 15:00 HKT/SGT

MoonstakeとStake Technologies、戦略的パートナーシップ締結 15:00 HKT/SGT

Moonstake Enters a Strategic Partnership with Stake Technologies to Enhance the Polkadot Ecosystem and Scale the DeFi Projects 15:00 HKT/SGT

WARC launches Prize for MENA Strategy 2021 13:30 HKT/SGT

TOYOTA、カムリを一部改良、より洗練されたスタイルへと深化 13:30 HKT/SGT

LEXUS、2020年の全世界販売実績を公表 13:30 HKT/SGT

Lasting Antiviral Effect against Covid-19 virus (SARS-CoV-2) by TAKEX CLEAN EXTRA 13:00 HKT/SGT

Lexus Announces 2020 Global Sales Results 12:40 HKT/SGT

宏华喜获电驱连续油管订单，同期首推一键联动自动化系统 12:32 HKT/SGT

宏華喜獲電驅連續油管訂單，同期首推一鍵聯動自動化系統 12:31 HKT/SGT

Honghua Wins Order For Electric Coiled Tubing And Launches Cutting-edge Rapid Tripping System 12:30 HKT/SGT

バイオジェンとエーザイは、アデュカヌマブの生物製剤ライセンス申請に関するFDAによる審査期間の3カ月延長を発表 11:00 HKT/SGT

エーザイ、パーキンソン病治療剤「エクフィナ(R)」を韓国において新発売 10:00 HKT/SGT

日立制御エッジコンピューター「CEシリーズ組み込みAIモデル」を販売開始 10:00 HKT/SGT

Eisai to Launch Parkinson's Disease Treatment Equfina in South Korea 08:35 HKT/SGT

Olympus launches comprehensive global educational platform for healthcare professionals 08:00 HKT/SGT

PuduBot Gets a Job at an Australian BBQ Restaurant 06:00 HKT/SGT

ACN Search:

Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25


Home \| About us \| Services \| Partners \| Events \| Login \| Contact us \| Cookies Policy \| Privacy Policy \| Disclaimer \| Terms of Use \| RSS

US: +1 214 890 4418 \| China: +86 181 2376 3721 \| Hong Kong: +852 8192 4922 \| Singapore: +65 6549 7068 \| Tokyo: +81 3 6859 8575